See more : RTX Corporation (5UR.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Qianjiang Yongan Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- TWi Biotechnology, Inc. (6610.TWO) Income Statement Analysis – Financial Results
- Nogin, Inc. (NOGNW) Income Statement Analysis – Financial Results
- Ramco Systems Limited (RAMCOSYS.BO) Income Statement Analysis – Financial Results
- DraftKings Inc. (DKNG1.MX) Income Statement Analysis – Financial Results
- Brd. Klee A/S (KLEE-B.CO) Income Statement Analysis – Financial Results
Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.chinataurine.com
About Qianjiang Yongan Pharmaceutical Co., Ltd.
Qianjiang Yongan Pharmaceutical Co., Ltd. manufactures and sells taurine in China. The company was founded in 2001 and is based in Qianjiang, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 972.89M | 1.46B | 1.57B | 1.17B | 1.37B | 1.01B | 932.77M | 549.40M | 555.89M | 658.42M | 522.72M | 470.70M | 417.01M | 319.73M | 310.30M | 447.49M | 314.99M | 156.70M |
| Cost of Revenue | 721.21M | 980.79M | 1.21B | 816.51M | 1.05B | 655.37M | 592.47M | 408.45M | 457.31M | 556.79M | 437.77M | 342.64M | 314.44M | 239.39M | 207.58M | 284.42M | 209.97M | 101.32M |
| Gross Profit | 251.68M | 481.66M | 358.54M | 356.35M | 318.72M | 350.04M | 340.31M | 140.95M | 98.58M | 101.63M | 84.95M | 128.06M | 102.58M | 80.34M | 102.72M | 163.06M | 105.02M | 55.38M |
| Gross Profit Ratio | 25.87% | 32.94% | 22.90% | 30.38% | 23.26% | 34.82% | 36.48% | 25.66% | 17.73% | 15.44% | 16.25% | 27.21% | 24.60% | 25.13% | 33.10% | 36.44% | 33.34% | 35.34% |
| Research & Development | 41.50M | 40.45M | 53.04M | 46.66M | 54.42M | 23.98M | 46.47M | 985.24K | 1.86M | 2.02M | 1.41M | 403.53K | 0.00 | 0.00 | 369.81K | 421.54K | 217.00K | 0.00 |
| General & Administrative | 85.78M | 88.48M | 27.07M | 28.40M | 22.30M | 11.41M | 15.59M | 9.41M | 8.48M | 8.48M | 6.91M | 6.06M | 15.01M | 20.46M | 4.14M | 5.44M | 4.45M | 5.13M |
| Selling & Marketing | 38.76M | 125.23M | 78.76M | 99.89M | 81.51M | 65.47M | 54.83M | 44.73M | 46.33M | 30.34M | 26.08M | 23.92M | 18.06M | 18.04M | 13.87M | 17.58M | 17.46M | 8.69M |
| SG&A | 174.96M | 213.70M | 105.84M | 128.28M | 103.81M | 76.88M | 70.42M | 54.13M | 54.81M | 38.82M | 32.99M | 29.98M | 33.06M | 38.50M | 18.00M | 23.02M | 21.92M | 13.82M |
| Other Expenses | 28.40M | 66.19M | 69.69M | 43.41M | 43.98M | -7.01K | 5.00M | 11.07M | 7.55M | 5.90M | 5.28M | -1.17M | 3.01M | 4.81M | 2.44M | 1.08M | 1.15M | -95.05K |
| Operating Expenses | 244.87M | 320.34M | 228.57M | 218.35M | 202.20M | 161.57M | 160.17M | 99.69M | 97.30M | 73.30M | 67.86M | 51.26M | 34.06M | 40.76M | 29.06M | 39.05M | 29.73M | 15.23M |
| Cost & Expenses | 967.24M | 1.30B | 1.44B | 1.03B | 1.25B | 816.94M | 752.63M | 508.14M | 554.61M | 630.09M | 505.63M | 393.90M | 348.49M | 280.14M | 236.64M | 323.48M | 239.69M | 116.55M |
| Interest Income | 1.88M | 338.73K | 154.78K | 1.48M | 2.56M | 2.87M | 1.28M | 919.69K | 981.57K | 1.01M | 3.82M | 6.08M | 7.71M | 8.74M | 1.65M | 1.04M | -0.20 | -0.59 |
| Interest Expense | 627.27K | 664.42K | 2.44M | 1.20M | 287.62K | 7.25K | 128.05K | 8.07M | 7.36M | 1.11M | 348.16K | 550.11K | 340.56K | 273.32K | 267.91K | 351.40K | 3.48M | 991.00K |
| Depreciation & Amortization | 135.18M | 123.57M | 115.96M | 113.07M | 112.76M | 79.80M | 69.82M | 71.33M | 69.78M | 55.65M | 40.38M | 18.94M | 16.45M | 13.40M | 10.67M | 7.81M | 6.50M | 2.23M |
| EBITDA | 139.20M | 293.38M | 240.75M | 242.59M | 226.07M | 291.87M | 241.66M | 112.04M | 66.39M | 83.98M | 58.13M | 101.51M | 97.44M | 65.02M | 85.71M | 127.54M | 81.80M | 40.77M |
| EBITDA Ratio | 14.31% | 21.85% | 16.86% | 22.56% | 18.09% | 29.31% | 28.01% | 20.82% | 14.35% | 14.29% | 11.12% | 21.73% | 20.88% | 20.41% | 28.01% | 28.50% | 26.35% | 26.02% |
| Operating Income | 5.65M | 152.40M | 131.67M | 133.97M | 117.62M | 212.29M | 151.82M | 62.95M | 13.40M | 32.73M | 22.42M | 89.82M | 77.98M | 46.82M | 72.60M | 119.75M | 71.08M | 38.54M |
| Operating Income Ratio | 0.58% | 10.42% | 8.41% | 11.42% | 8.58% | 21.12% | 16.28% | 11.46% | 2.41% | 4.97% | 4.29% | 19.08% | 18.70% | 14.64% | 23.40% | 26.76% | 22.57% | 24.60% |
| Total Other Income/Expenses | 403.43K | 658.46K | -1.82M | -3.39M | -1.27M | -231.90K | 5.03M | 10.76M | 7.47M | 4.45M | 5.26M | 12.63M | 14.90M | 12.53M | 1.38M | 1.08M | 783.90K | -95.05K |
| Income Before Tax | 6.05M | 153.06M | 129.85M | 130.58M | 116.35M | 212.06M | 156.85M | 73.33M | 20.86M | 37.19M | 27.68M | 88.66M | 80.99M | 51.62M | 75.04M | 120.83M | 71.87M | 38.45M |
| Income Before Tax Ratio | 0.62% | 10.47% | 8.29% | 11.13% | 8.49% | 21.09% | 16.82% | 13.35% | 3.75% | 5.65% | 5.30% | 18.84% | 19.42% | 16.15% | 24.18% | 27.00% | 22.82% | 24.53% |
| Income Tax Expense | 34.47M | 20.34M | 10.81M | 11.92M | 9.44M | 33.16M | 23.90M | 11.34M | 3.68M | 5.46M | 4.67M | 13.30M | 11.23M | 5.52M | 9.99M | 18.25M | 2.92M | 984.87K |
| Net Income | -12.31M | 140.35M | 111.42M | 105.56M | 89.93M | 178.58M | 133.15M | 62.30M | 17.61M | 31.72M | 23.01M | 75.36M | 69.77M | 46.11M | 65.05M | 102.58M | 68.95M | 37.46M |
| Net Income Ratio | -1.27% | 9.60% | 7.12% | 9.00% | 6.56% | 17.76% | 14.27% | 11.34% | 3.17% | 4.82% | 4.40% | 16.01% | 16.73% | 14.42% | 20.96% | 22.92% | 21.89% | 23.91% |
| EPS | -0.04 | 0.48 | 0.38 | 0.37 | 0.31 | 0.62 | 0.46 | 0.22 | 0.06 | 0.11 | 0.08 | 0.27 | 0.25 | 0.17 | 0.31 | 0.49 | 0.37 | 0.23 |
| EPS Diluted | -0.04 | 0.48 | 0.38 | 0.37 | 0.31 | 0.62 | 0.46 | 0.22 | 0.06 | 0.11 | 0.08 | 0.27 | 0.25 | 0.17 | 0.31 | 0.49 | 0.37 | 0.23 |
| Weighted Avg Shares Out | 294.56M | 294.32M | 294.68M | 288.49M | 288.34M | 289.56M | 290.22M | 280.50M | 280.50M | 279.90M | 287.58M | 282.55M | 282.84M | 266.00M | 209.85M | 210.00M | 187.50M | 165.01M |
| Weighted Avg Shares Out (Dil) | 294.68M | 294.68M | 294.68M | 288.51M | 288.34M | 289.91M | 291.61M | 283.17M | 293.54M | 280.56M | 287.58M | 282.59M | 282.84M | 266.00M | 209.85M | 210.00M | 187.50M | 165.01M |
No news found for: 002365.SZ
Source: https://incomestatements.info
Category: Stock Reports